Rabeximod

N/A

Report date: 2022/11/25 17:56:38
NME

Base Information

Drug NameRabeximod
Drug Alias Name雷贝莫德RabeximodumRob-803
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell differentiation modulators
TargetsNot applicable
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaSweden +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxypharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxypharma Ab
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksDrugBank